BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31247697)

  • 1. [A Case of Isolated Peritoneal Metastasis from Prostate Cancer].
    Uketa S; Shimizu Y; Ogawa K; Utsunomiya N; Katsushima H; Ishihara M; Hashimoto K; Kanamaru S
    Hinyokika Kiyo; 2019 May; 65(5):175-179. PubMed ID: 31247697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Solitary peritoneal carcinomatosis in prostate cancer].
    Brehmer B; Makris A; Wellmann A; Jakse G
    Aktuelle Urol; 2007 Sep; 38(5):408-9. PubMed ID: 17907070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful complete androgen blockade (CAB) therapy for prostatic cancer detected from multiple lung metastases: a case report].
    Tokumitsu M; Inada F; Kitahara K; Kawakami N; Masui N; Ishida H; Ishida H; Saga Y; Hashimoto H; Yachiku S
    Hinyokika Kiyo; 2001 Jan; 47(1):59-62. PubMed ID: 11235226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.
    Soga N; Onishi T; Arima K; Sugimura Y
    Int J Urol; 2007 Mar; 14(3):192-6; discussion 197. PubMed ID: 17430253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.
    Kijima T; Fujii Y; Yokoyama M; Ishioka J; Matsuoka Y; Numao N; Saito K; Koga F; Masuda H; Kawakami S; Kihara K
    BJU Int; 2012 Oct; 110(8):1149-55. PubMed ID: 22369348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and nadir prostate-specific antigen (PSA) according to initial PSA levels in primary androgen deprivation therapy for metastatic prostate cancer.
    Kitagawa Y; Ueno S; Izumi K; Kadono Y; Mizokami A; Hinotsu S; Akaza H; Namiki M
    World J Urol; 2016 Mar; 34(3):319-27. PubMed ID: 26089252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
    Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
    Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delay in High-Grade Metastatic Prostate Cancer Progression by Dutasteride : A Case Report].
    Yamada Y; Fujiwara H; Somiya S; Fujikawa S; Kamiyama Y; Tamaki M; Kanaoka T
    Hinyokika Kiyo; 2018 Apr; 64(4):187-192. PubMed ID: 29772622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node-positive prostate cancer: evaluation of the results of the combination of androgen deprivation therapy and radiation therapy.
    Buskirk SJ; Pisansky TM; Atkinson EJ; Schild SE; O'Brien PC; Wolfe JT; Zincke H
    Mayo Clin Proc; 2001 Jul; 76(7):702-6. PubMed ID: 11444402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostatic cancer with multiple pulmonary metastases treated successfully with hormonal therapy: a case report].
    Fukuda M; Takashima H; Fuse H; Hirano S
    Hinyokika Kiyo; 2002 Aug; 48(8):499-502. PubMed ID: 12243078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated Peritoneal Metastasis of Prostate Cancer Presenting with Massive Ascites: A Case Report.
    Jang HR; Lee K; Lim KH
    Curr Oncol; 2022 Jun; 29(7):4423-4427. PubMed ID: 35877211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer?
    Labrie F; Candas B; Gomez JL; Cusan L
    Urology; 2002 Jul; 60(1):115-9. PubMed ID: 12100935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flutamide withdrawal plus hydrocortisone resulted in clinical complete response in a patient with prostate carcinoma.
    Figg WD; Kroog G; Duray P; Walther MM; Patronas N; Sartor O; Reed E
    Cancer; 1997 May; 79(10):1964-8. PubMed ID: 9149024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple myeloma diagnosed during hormonal therapy for prostate cancer: report of two cases].
    Yoshinaga A; Okada Y; Ichiyanagi N; Kamata S
    Hinyokika Kiyo; 2012 May; 58(5):243-7. PubMed ID: 22767278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroendocrine carcinoma of the prostate effectively treated by cisplatin and irinotecan--a case report].
    Inoue S; Oka K; Araki T; Yano A; Tacho T; Fujii M; Kimoto K; Murakami M; Ohshiro Y
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1323-5. PubMed ID: 17687224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Port-Site Metastasis of Prostate Cancer after Robot-Assisted Laparoscopic Prostatectomy : A Case Report].
    Ikeuchi R; Sunada T; Yoshikawa T; Yoshida T; Iwasa Y; Segawa T
    Hinyokika Kiyo; 2017 Feb; 63(2):87-91. PubMed ID: 28264539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Ureteral Metastasis from Prostate Cancer].
    Matsukawa A; Shimizu Y; Uketa S; Ogawa K; Utsunomiya N; Katsushima H; Asai S; Ishihara M; Hashimoto K; Kanamaru S
    Hinyokika Kiyo; 2021 Apr; 67(4):171-176. PubMed ID: 34107615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.
    Smith MR; Kabbinavar F; Saad F; Hussain A; Gittelman MC; Bilhartz DL; Wynne C; Murray R; Zinner NR; Schulman C; Linnartz R; Zheng M; Goessl C; Hei YJ; Small EJ; Cook R; Higano CS
    J Clin Oncol; 2005 May; 23(13):2918-25. PubMed ID: 15860850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of locally advanced prostate cancer with low serum testosterone associated with intake of an androgenic medicine].
    Sakura M; Tsukamoto T; Yonese J; Nakaishi M; Maezawa T; Takimoto K; Fukui I
    Nihon Hinyokika Gakkai Zasshi; 2003 May; 94(4):529-32. PubMed ID: 12795169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.